Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in Korea.
Jung Hyun KwonMyeong Jun SongJeong Won JangSi Hyun BaeJong Young ChoiSeung Kew YoonHee Yeon KimChang Wook KimDo Seon SongU Im ChangJin Mo YangChan Ran YouSang Wook ChoiHae Lim LeeSung Won LeeNam Ik HanSoon Woo NamSang Gyune KimYoung Seok KimSeok Hyun KimByung Seok LeeTae Hee LeeEun-Young ChoPublished in: Digestive diseases and sciences (2019)
TDF therapy induced sustained viral suppression and had a favorable safety profile over a 3-year period. However, close monitoring of renal function should be mandatory in treating CHB patients receiving TDF, particularly older patients.